Is Boston Scientific Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Boston Scientific Corp (BSX) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Boston Scientific Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Boston Scientific Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Boston Scientific Corp?

Muslim investors may consider investing in Boston Scientific Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Boston Scientific Corp classified as HALAL?

Musaffa determines the Shariah status of Boston Scientific Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Boston Scientific Corp updated?

The Shariah compliance status of Boston Scientific Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Boston Scientific Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Boston Scientific Corp?

You can check the latest Shariah compliance status of Boston Scientific Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BSX Shariah Compliance

Screening Methodology: AAOIFI

UNLOCK FOR FREE

Last Updated: February 24, 2026

Report Source: 2025 Annual Report

Boston Scientific Corp. Stock Analysis BSX

United States Health Care Large Cap Report: 2025 Annual

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 53,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Key Statistics of Boston Scientific Corp (BSX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$62.13$63.55

Today's Open

$62.84

Volume

14.97M

P/E Ratio (TTM)

31.94

52 Week Range

$60.59$109.50

Market Cap

138.71B

Avg. Volume

15.44M

Dividend Yield

Financial Metrics & Statements of Boston Scientific Corp (BSX)

FAQ's for Boston Scientific Corp (BSX)

According to Musaffa’s Shariah screening methodology, Boston Scientific Corp (BSX) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.